Article
Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor-/- mice.
Arteriosclerosis, thrombosis, and vascular biology - 1 May 2010
Bietrix Florence, Lombardo Elisa, van Roomen Cindy P A A, Ottenhoff Roelof, Vos Mariska, Rensen Patrick C N, Verhoeven Arthur J, Aerts Johannes M, Groen Albert K
Abstract excerpt
OBJECTIVE: The iminosugar N-(5'-adamantane-1'-yl-methoxy)-pentyl-1-deoxynoijirimycin (AMP-DNM), an inhibitor of the enzyme glucosylceramide synthase catalyzing glycosphingolipid (GSL) biosynthesis, ameliorates diabetes and reduces liver steatosis in ob/ob mice. Because an accumulation of sphingol...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.